Skip to main content

Drug Absorption

2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

AB Science
AB ScienceFrance - Paris
2 programs
2
berberinePhase 11 trial
ginsengPhase 11 trial
Active Trials
NCT04918667Not Yet Recruiting16Est. Dec 2026
NCT04932265Suspended3Est. Dec 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AB Scienceberberine
AB Scienceginseng

Clinical Trials (2)

Total enrollment: 19 patients across 2 trials

Effect of Gamma-cyclodextrin on the Bioavailability of Berberine

Start: Sep 2024Est. completion: Dec 202616 patients
Phase 1Not Yet Recruiting

Effect of Gamma-cyclodextrin on the Bioavailability of Ginsenosides

Start: Sep 2021Est. completion: Dec 20253 patients
Phase 1Suspended

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.